FI923841A0 - Substituerade mandelsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. - Google Patents

Substituerade mandelsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.

Info

Publication number
FI923841A0
FI923841A0 FI923841A FI923841A FI923841A0 FI 923841 A0 FI923841 A0 FI 923841A0 FI 923841 A FI923841 A FI 923841A FI 923841 A FI923841 A FI 923841A FI 923841 A0 FI923841 A0 FI 923841A0
Authority
FI
Finland
Prior art keywords
deras
mandelsyraderivat
substitute
foerfarande foer
framstaellning och
Prior art date
Application number
FI923841A
Other languages
English (en)
Other versions
FI101222B (fi
FI101222B1 (fi
FI923841A (fi
Inventor
Klaus-Helmut Mohrs
Siegfried Raddatz
Michael Matzke
Romanis Fruchtmann
Armin Hatzelmann
Christian Kohldorfer
Rainer Mueller-Peddinghaus
Pia Theisen-Popp
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI923841A0 publication Critical patent/FI923841A0/fi
Publication of FI923841A publication Critical patent/FI923841A/fi
Application granted granted Critical
Publication of FI101222B publication Critical patent/FI101222B/fi
Publication of FI101222B1 publication Critical patent/FI101222B1/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Measurement Of Force In General (AREA)
  • Vessels, Lead-In Wires, Accessory Apparatuses For Cathode-Ray Tubes (AREA)
  • Moulding By Coating Moulds (AREA)
  • Sewage (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI923841A 1991-08-29 1992-08-27 Menetelmä terapeuttisesti aktiivisten kinolin-2-yylimetoksifenyylijohdannaisten valmistamiseksi FI101222B1 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4128681 1991-08-29
DE4128681A DE4128681A1 (de) 1991-08-29 1991-08-29 Substituierte mandelsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Publications (4)

Publication Number Publication Date
FI923841A0 true FI923841A0 (fi) 1992-08-27
FI923841A FI923841A (fi) 1993-03-01
FI101222B FI101222B (fi) 1998-05-15
FI101222B1 FI101222B1 (fi) 1998-05-15

Family

ID=6439400

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923841A FI101222B1 (fi) 1991-08-29 1992-08-27 Menetelmä terapeuttisesti aktiivisten kinolin-2-yylimetoksifenyylijohdannaisten valmistamiseksi

Country Status (21)

Country Link
US (1) US5292769A (fi)
EP (1) EP0529450B1 (fi)
JP (1) JPH05194402A (fi)
KR (1) KR930004270A (fi)
AT (1) ATE115949T1 (fi)
AU (1) AU643628B2 (fi)
CA (1) CA2076929A1 (fi)
CZ (1) CZ281501B6 (fi)
DE (2) DE4128681A1 (fi)
DK (1) DK0529450T3 (fi)
ES (1) ES2065737T3 (fi)
FI (1) FI101222B1 (fi)
GR (1) GR3015457T3 (fi)
HU (1) HU214577B (fi)
IL (1) IL102949A (fi)
MX (1) MX9204748A (fi)
MY (1) MY110206A (fi)
RU (1) RU2066315C1 (fi)
SK (1) SK279066B6 (fi)
TW (1) TW207995B (fi)
ZA (1) ZA926536B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4219765A1 (de) * 1992-06-17 1993-12-23 Bayer Ag Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenylessigsäurederivate
US5512581A (en) * 1994-07-18 1996-04-30 Abbott Laboratories Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
DE4443891A1 (de) 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
US8719041B2 (en) * 2002-06-10 2014-05-06 Ebay Inc. Method and system for customizing a network-based transaction facility seller application
TW200410921A (en) * 2002-11-25 2004-07-01 Hoffmann La Roche Mandelic acid derivatives
BRPI0417543A (pt) 2003-12-12 2007-03-27 Wyeth Corp quinolinas úteis no tratamento de doença cardiovascular
EP2086531A4 (en) 2006-11-30 2009-09-30 Amira Pharmaceuticals Inc COMPOSITIONS AND TREATMENTS COMPRISING 5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITORS AND NITRIC OXIDE MODULATORS
ES2878405T3 (es) 2014-02-04 2021-11-18 Bioscience Pharma Partners Llc Uso de inhibidores de flap para reducir la lesión mediada por neuroinflamación en el sistema nervioso central

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate

Also Published As

Publication number Publication date
HUT67137A (en) 1995-02-28
AU2137192A (en) 1993-03-04
CZ263992A3 (en) 1993-08-11
ATE115949T1 (de) 1995-01-15
SK263992A3 (en) 1998-06-03
HU214577B (hu) 1998-04-28
US5292769A (en) 1994-03-08
SK279066B6 (sk) 1998-06-03
TW207995B (fi) 1993-06-21
CA2076929A1 (en) 1993-03-01
HU9202780D0 (en) 1992-12-28
KR930004270A (ko) 1993-03-22
AU643628B2 (en) 1993-11-18
DE59201013D1 (de) 1995-02-02
IL102949A0 (en) 1993-01-31
RU2066315C1 (ru) 1996-09-10
GR3015457T3 (en) 1995-06-30
DE4128681A1 (de) 1993-03-04
ES2065737T3 (es) 1995-02-16
EP0529450A1 (de) 1993-03-03
DK0529450T3 (da) 1995-05-15
FI101222B (fi) 1998-05-15
MX9204748A (es) 1993-02-01
FI101222B1 (fi) 1998-05-15
IL102949A (en) 1997-02-18
EP0529450B1 (de) 1994-12-21
JPH05194402A (ja) 1993-08-03
ZA926536B (en) 1993-03-05
MY110206A (en) 1998-02-28
FI923841A (fi) 1993-03-01
CZ281501B6 (cs) 1996-10-16

Similar Documents

Publication Publication Date Title
FI810604L (fi) Foerfarande foer framstaellning av indanderivat
FI925549A0 (fi) Nya azaheterocyklylmetyl-kromaner
NO301542B1 (no) Nye pyrazin-derivater
FI923841A0 (fi) Substituerade mandelsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI872719A0 (fi) Nya tetrahydro-benzotiazoler, deras framstaellning och anvaendning.
FR2640969B1 (fi)
ES2144271T3 (es) Sintesis de derivados de acido carboxilico.
JPS5293755A (en) Preparation of carboxylic acid derivatives
JPS51144790A (en) Process for preparing l-cysteine derivatives
DK0518769T3 (da) Hidtil ukendte ethanolaminbenzoatderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem.
JPS532476A (en) Synthesis of 4-substituted-dithio-2-azetidinone derivatives
JPS5233647A (en) Preparation of butyrosine a derivatives
JPS52156996A (en) Preparation of l-tryptophan
JPS5219654A (en) Preparation of ng-substituted-n2- substituted-alginamides and acid add ition salts thereof
JPS5297924A (en) Benzyl alcohol derivatives
JPS52156992A (en) Preparation of l-serine
JPS5253854A (en) Preparing optical active pyprolidine ethanols
JPS52118443A (en) Synthesis of 3-methyl-3-(4-isobutylphenyl)pyruvic acid
GB973577A (en) Yohimbane derivatives and a process for their preparation
JPS5362836A (en) Anticarcinogens
JPS5432450A (en) Preparation of 2-n-pentylcyclopentanone derivative
TH13275EX (th) สารต่อต้านการออกซิไดส์ชนิดใหม่
JPS51115464A (en) Method for preparing l-ascorbic acid-2-sulfuric ester or its salts
JPS5356643A (en) Trans-4-aminomethylcyclohexane-carboxylic acid ester
JPS5246066A (en) Preparation of optically active 5-oxo-2-pyrrolipinyl acetic acid salts